DK1007537T3 - Receptor-protein med betegnelsen 2F1 - Google Patents
Receptor-protein med betegnelsen 2F1Info
- Publication number
- DK1007537T3 DK1007537T3 DK97905729T DK97905729T DK1007537T3 DK 1007537 T3 DK1007537 T3 DK 1007537T3 DK 97905729 T DK97905729 T DK 97905729T DK 97905729 T DK97905729 T DK 97905729T DK 1007537 T3 DK1007537 T3 DK 1007537T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor protein
- polypeptides
- protein designated
- soluble
- producing
- Prior art date
Links
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/604,333 US5776731A (en) | 1996-02-21 | 1996-02-21 | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| PCT/US1997/001697 WO1997031010A1 (fr) | 1996-02-21 | 1997-02-06 | Proteine receptrice designee par 2f1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007537T3 true DK1007537T3 (da) | 2007-11-19 |
Family
ID=24419190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97905729T DK1007537T3 (da) | 1996-02-21 | 1997-02-06 | Receptor-protein med betegnelsen 2F1 |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US5776731A (fr) |
| EP (1) | EP1007537B1 (fr) |
| JP (1) | JP4082733B2 (fr) |
| AT (1) | ATE368682T1 (fr) |
| AU (1) | AU720943B2 (fr) |
| CA (1) | CA2245496C (fr) |
| DE (2) | DE97905729T1 (fr) |
| DK (1) | DK1007537T3 (fr) |
| ES (1) | ES2287950T3 (fr) |
| NZ (1) | NZ331176A (fr) |
| PT (1) | PT1007537E (fr) |
| WO (1) | WO1997031010A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776731A (en) * | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| US7141393B2 (en) * | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| JP3955352B2 (ja) | 1997-02-25 | 2007-08-08 | 株式会社林原生物化学研究所 | 破骨細胞形成阻害剤 |
| US6087116A (en) * | 1997-03-12 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18 (IL-18) receptor polypeptides and their uses |
| WO1998049305A1 (fr) * | 1997-05-01 | 1998-11-05 | Amgen Inc. | Polypeptides opg chimeres |
| US7393663B2 (en) * | 1997-08-01 | 2008-07-01 | Serono Genetics Institute S.A. | Expressed sequence tags and encoded human proteins |
| US7220717B2 (en) * | 1997-08-14 | 2007-05-22 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use |
| US7704944B2 (en) * | 1997-08-14 | 2010-04-27 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| US6326472B1 (en) * | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| PT1047781E (pt) | 1998-01-23 | 2004-11-30 | Immunex Corp | Receptores de il-18 |
| CA2276216A1 (fr) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Peptide artificiel capable de neutraliser l'activite biologique de l'interleukine-18 |
| US7029861B1 (en) | 1998-09-15 | 2006-04-18 | Board Of Regents, The University Of Texas System | LPS-response gene compositions and methods |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| AU2001248839A1 (en) * | 2000-04-25 | 2001-11-07 | Tomoaki Hoshino | Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same |
| WO2001087328A2 (fr) * | 2000-05-12 | 2001-11-22 | Immunex Corporation | Inhibiteurs d"interleukine 1 dans le traitement de maladies |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| JP4696382B2 (ja) * | 2001-03-21 | 2011-06-08 | アイシン精機株式会社 | 三本鎖dnaの形成方法 |
| ATE431406T1 (de) * | 2002-02-25 | 2009-05-15 | Genentech Inc | Neuer typ-1-cytokinrezeptor glm-r |
| JP2006508056A (ja) | 2002-08-28 | 2006-03-09 | イミュネックス・コーポレーション | 心臓血管疾患を治療するための組成物および方法 |
| AU2011226823B2 (en) * | 2004-07-16 | 2012-09-20 | Atsuo Sekiyama | IL-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| AU2005264453B2 (en) * | 2004-07-16 | 2011-07-14 | Atsuo Sekiyama | IL-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| AU2007217430A1 (en) * | 2006-02-22 | 2007-08-30 | University Of Zurich | Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| CL2008002153A1 (es) | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
| BR112014003434A2 (pt) | 2011-08-15 | 2017-03-01 | Abbott Lab | processo para produção de hmb e seus sais |
| WO2020163715A1 (fr) * | 2019-02-08 | 2020-08-13 | Cedars-Sinai Medical Center | Méthodes, compositions et kits pour traiter une maladie inflammatoire ciblant il18r1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004838A1 (fr) * | 1987-11-25 | 1989-06-01 | Immunex Corporation | Recepteurs d'interleukine-1 |
| US5853721A (en) * | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
| US5776731A (en) * | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| US6326472B1 (en) * | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
-
1996
- 1996-02-21 US US08/604,333 patent/US5776731A/en not_active Expired - Lifetime
-
1997
- 1997-02-06 CA CA2245496A patent/CA2245496C/fr not_active Expired - Fee Related
- 1997-02-06 NZ NZ331176A patent/NZ331176A/xx not_active IP Right Cessation
- 1997-02-06 JP JP53018097A patent/JP4082733B2/ja not_active Expired - Fee Related
- 1997-02-06 DE DE97905729T patent/DE97905729T1/de active Pending
- 1997-02-06 AT AT97905729T patent/ATE368682T1/de active
- 1997-02-06 EP EP97905729A patent/EP1007537B1/fr not_active Expired - Lifetime
- 1997-02-06 ES ES97905729T patent/ES2287950T3/es not_active Expired - Lifetime
- 1997-02-06 AU AU22553/97A patent/AU720943B2/en not_active Ceased
- 1997-02-06 DE DE69737978T patent/DE69737978T2/de not_active Expired - Lifetime
- 1997-02-06 WO PCT/US1997/001697 patent/WO1997031010A1/fr not_active Ceased
- 1997-02-06 PT PT97905729T patent/PT1007537E/pt unknown
- 1997-02-06 DK DK97905729T patent/DK1007537T3/da active
-
1998
- 1998-07-06 US US09/110,618 patent/US6090918A/en not_active Expired - Lifetime
-
2000
- 2000-05-24 US US09/578,178 patent/US6451760B1/en not_active Expired - Fee Related
- 2000-05-24 US US09/577,806 patent/US6492496B1/en not_active Expired - Fee Related
-
2002
- 2002-05-28 US US10/157,447 patent/US7001599B2/en not_active Expired - Fee Related
-
2004
- 2004-05-28 US US10/857,664 patent/US7235238B2/en not_active Expired - Fee Related
-
2007
- 2007-06-25 US US11/768,156 patent/US7625710B2/en not_active Expired - Fee Related
-
2009
- 2009-10-22 US US12/604,289 patent/US8034343B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040253682A1 (en) | 2004-12-16 |
| NZ331176A (en) | 2000-10-27 |
| US8034343B2 (en) | 2011-10-11 |
| PT1007537E (pt) | 2007-11-09 |
| US7001599B2 (en) | 2006-02-21 |
| DE97905729T1 (de) | 2005-05-04 |
| WO1997031010A1 (fr) | 1997-08-28 |
| JP2000506005A (ja) | 2000-05-23 |
| EP1007537A4 (fr) | 2001-06-13 |
| US20100080804A1 (en) | 2010-04-01 |
| US6492496B1 (en) | 2002-12-10 |
| US7625710B2 (en) | 2009-12-01 |
| US20020143155A1 (en) | 2002-10-03 |
| AU720943B2 (en) | 2000-06-15 |
| CA2245496A1 (fr) | 1997-08-28 |
| US6451760B1 (en) | 2002-09-17 |
| DE69737978D1 (de) | 2007-09-13 |
| US5776731A (en) | 1998-07-07 |
| EP1007537A1 (fr) | 2000-06-14 |
| AU2255397A (en) | 1997-09-10 |
| US20080213793A1 (en) | 2008-09-04 |
| US7235238B2 (en) | 2007-06-26 |
| ES2287950T3 (es) | 2007-12-16 |
| CA2245496C (fr) | 2012-03-27 |
| JP4082733B2 (ja) | 2008-04-30 |
| US6090918A (en) | 2000-07-18 |
| EP1007537B1 (fr) | 2007-08-01 |
| ATE368682T1 (de) | 2007-08-15 |
| DE69737978T2 (de) | 2008-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
| ATE286907T1 (de) | Cytokinin-designiertes lerk-5 | |
| DK0883687T3 (da) | C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf | |
| TR200100056T2 (tr) | Nörotrofik faktörler | |
| CY1106382T1 (el) | Αντισωματα anti-vegf | |
| ATE353906T1 (de) | Cd27 ligand | |
| DK0667912T3 (da) | Defekte adenovirusvektorer og anvendelse heraf i genterapi | |
| ES2235353T3 (es) | Naftridonas para inhibir la proteina tirasina quinasa y proliferacion celular mediada por la quinasa del ciclo celular. | |
| BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
| NZ335485A (en) | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | |
| TR199902818T2 (xx) | Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler. | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| DK0960127T3 (da) | Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf | |
| DE69805237D1 (de) | Tumornekrose zugehöriger Rezeptor, TR4 | |
| DE69535719D1 (de) | Fas-antigenbindender ligand | |
| NO995182L (no) | Pattedyrcytokinlignende faktor 7 | |
| NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
| BR0010563A (pt) | Composições isoladas de células da pele e métodos para seu uso | |
| DK1144666T3 (da) | Replikationsdeficient baculovirusekspressionssystem | |
| DK0745122T3 (da) | Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf | |
| DE60139113D1 (de) | 18477, eine menschliche proteinkinase und deren verwendung | |
| DE69130845D1 (de) | HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung | |
| NO20020329D0 (no) | Antitumor antistoffer, proteiner og anvendelser derav | |
| PE20399A1 (es) | Muteina ob |